Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$16,311,556
+$2,350,873 QoQ
Shares Held
64,821
+1.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#701
of 4,153 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$25,164
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIVERSIFY WEALTH MANAGEMENT, LLC holds $87,794,871 across 13 Drug Manufacturers - General names. ABBV ranks #3 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
94,734 | $24,059,593 | |
| 2 | LLY |
ELI LILLY & Co
|
16,684 | $20,011,291 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
64,821 | $16,311,556 | |
| 4 | AMGN |
Amgen Inc
|
22,302 | $8,076,000 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,135 | $3,743,847 | |
| 6 | NVS |
Novartis AG
|
20,054 | $3,142,862 | |
| 7 | PFE |
Pfizer Inc
|
117,466 | $2,828,581 | |
| 8 | GSK |
GSK plc
|
43,867 | $2,299,508 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,164 | 100 | Call | Sole | 2026-07-30 | |
| 2026-06-30 | $16,311,556 | 64,821 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $204 | 100 | Call | Sole | 2026-05-01 | |
| 2026-03-31 | $13,960,683 | 64,190 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $7,842,233 | 34,322 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $7,841,102 | 33,865 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,099,101 | 32,858 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,062,251 | 28,934 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $4,555,339 | 25,635 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $3,119,196 | 15,795 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $2,309,859 | 13,467 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||